Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1)
- Eur J Med Chem. 2013 Apr:62:148-57. doi: 10.1016/j.ejmech.2012.09.047.
- 1. Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
A series of MMP-1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure-based drug design methods. The best compound in the series showed an IC50 value of 0.4 μM. A docking study was conducted for compound (S)-10n in order to investigate its binding interactions with MMP-1. The structure-activity relationships (SAR) were also briefly discussed. Useful SAR was established which provides important guidelines for the design of future generations of potent inhibitors against MMP-1.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Tyrosinase; Phosphatase; Cholinesterase (ChE); SARS-CoV; PERK; JNK; p38 MAPK; TGF-beta/Smad; Apoptosis; Reactive Oxygen Species (ROS); AMPK; MMPResearch Areas: Neurological Disease; Inflammation/Immunology; Infection; Cardiovascular Disease; Cancer